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Summary  Non-melanoma  skin  cancer  is  the  most  common  cancer  lesion  worldwide.  In  Brazil,
it  represents  95%  of  all  skin  cancer  lesions,  and  25%  of  all  tumor  types.  Early  diagnosis  allows
treatment  at  initial  stages  of  the  disease,  improving  patient’s  prognosis.  Thus,  it  is  of  great
importance  the  development  of  techniques  to  aid  diagnosis,  such  as  marked  ﬂuorescence,  which
we  propose  here  for  early  detection  of  skin  cancer  lesions.  In  this  study,  we  use  a  photosensi-
tive  substance,  aminolaevulinic  acid  (ALA),  as  biomarkers,  and  analyze  its  in  situ  ﬂuorescence
response  to  light  excitation.  The  use  of  ALA  as  a  biomarker  precursor  is  interesting  because
it  shows  selectivity  for  protoporphyrin  IX  production/concentration  in  abnormal  cells.  Proto-
porphyrin  IX  shows  high  ﬂuorescence  yield  when  excited  with  UV-blue  light.  In  this  study,  ALA
solutions  (at  5%  and  10%  concentrations)  were  applied  to  malignant  (basal  cell  carcinoma)  and
potentially  malignant  skin  lesions  (actinic  and  seborrheic  keratoses),  aiming  to  investigate  our
ability  in  detecting  and  distinguishing  them  by  using  this  technique.  At  regular  time  intervals
(15,  30,  45  and  60  min),  ﬂuorescence  images  were  collected  with  a  prototype  system  for  wide-
ﬁeld  ﬂuorescence  imaging.  ALA  has  provided  a  marked  ﬂuorescence  that  allowed  signiﬁcant
discrimination  of  normal  and  tumor.  Potentially  malignant  and  benign  lesions  were  all  well-
identiﬁed  by  their  autoﬂuorescence;  photodynamic  detection  did  not  improve  diagnostics.  This
technique  also  provided  a  better  delineation  of  the  lesion  margins,  which  is  very  important  for
an  effective  treatment  of  malignant,  potentially  malignant  and  benign  skin  lesions.
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Introduction
Skin  cancer  can  be  classiﬁed  in  two  major  groups:  non-
melanoma  and  melanoma.  Non-melanoma  lesions  are  the
most  common  ones,  with  estimative  between  2  and  3  million
cases  per  year  around  the  world  [1,2].
The  most  common  non-melanoma  skin  cancer  is  the  basal
cell  carcinoma  (BCC),  originated  in  the  basal  layer  of  epi-
dermis.  Its  occurrence  is  higher  in  middle-aged  and  elderly
people  with  skin  phototype  I  or  II,  and  its  appearance  is
directly  related  to  prolonged  exposure  to  solar  radiation
throughout  life.  It  is  usually  observed  at  body  areas  exposed
to  the  sun,  such  as  arms,  face  and  neck  [2—6].
Others  non-malignant,  but  also  important,  skin  lesions  —
due  to  the  large  occurrence  and  possibility  of  misdiagnosis
—  are  actinic  keratosis  (AK)  and  seborrheic  keratosis  (SK).
Actinic  keratosis  is  a  skin  epidermal  dysplasia  that  develops
due  to  the  cumulative  effect  of  ultraviolet  radiation  from
sun  exposure.  It  is  more  prevalent  at  the  same  population
group  as  for  skin  cancer  and  presents  a  higher  incidence  on
face,  scalp,  arms  and  hands.  The  seborrheic  keratosis,  usu-
ally  associated  to  genetic  origin,  affects  mainly  the  chest
and  face,  but  it  can  occur  also  in  the  limbs.  These  lesions
have  a  warty  appearance,  irregular  surface  and  a  soft  con-
sistency  [3—5].  Therefore,  being  able  to  differentiate  these
lesions  is  of  relevance  for  clinical  diagnosis.
Prevention  and  detection  are  the  major  challenges  in
dealing  with  skin  cancer:  prevention  depends  mainly  on
the  use  of  sunscreen  and  avoidance  of  exposure  to  high
ultraviolet  irradiation,  and  early  diagnosis  improves  patient
prognosis,  and  reduces  patient  morbidity,  as  well  as  treat-
ment  complexity  and  costs  [4,5,7,8].
Skin  diagnosis  is  initiated  with  whole  body  visualization
under  illumination  with  white  light  sources,  during  the  clini-
cal  examination.  If  any  lesion  is  identiﬁed,  a  dermatoscopic
examination  is  performed  to  obtain  additional  details.  This
equipment  magniﬁes  the  visualization  ﬁeld  in  10  up  to  40
times.  When  a  malignant  condition  is  suspected,  a  biopsy
is  performed.  Histopathological  analysis  is  ‘‘gold  standard’’
for  tissue  diagnosis.  Clinical  characteristics  of  benign  lesions
and  carcinomas  at  early  stage  are  similar,  and  the  large  vari-
ability  of  professional  skills  to  recognize  early  malignant
features  result  in  a  non-efﬁcient  inter-lesion  discrimina-
tion.  Biopsy  is  an  invasive  technique  which  does  not  provide
information  of  lesion  margins,  which  is  relevant  for  treat-
ment  planning,  since  surgical  resection  of  the  lesion  has
to  be  performed  beyond  the  clinically  apparent  margin  for
the  malignant  conditions.  For  the  lesions  in  areas  of  cos-
metic  relevance  or  in  surgically  complex  anatomic  regions,
especially  in  face  and  scalp,  the  treatment  must  consider
removing  the  least  possible  amount  of  healthy  tissue  [9,10].
The  detection  of  lesions  using  illumination  parameters
distinct  to  the  conventional  white  light,  and  the  ﬂuores-
cence  visualization  has  the  potential  to  increase  in  situ
tissue  discrimination.  Among  optical  techniques  for  tissue
diagnostics,  one  of  the  most  investigated  one  is  autoﬂuores-
cence  [11—14],  because  tissue  biochemical  and  structural
changes  that  take  place  during  cancer  development  and
progression  alter  the  light—tissue  interactions.  Tissue  ﬂuo-
rescence  patterns  also  depend  on  these  interactions.  Thus,
ﬂuorescence  is  capable  of  detecting  such  changes.  At  skin,
autoﬂuorescence  helps  in  the  detection  and  delineation  of
tumor  margins,  limiting  damage  caused  by  the  tumor  recur-
rence  due  to  an  incomplete  surgical  removal  [11].  The  use
of  skin  ﬂuorescence  also  aids  in  distinguishing  tumor  from
healthy  tissue  [12]  and  benign  lesions  [13].
The  photodiagnosis  using  an  exogenous  marker  can
increase  the  contrast  resolution  between  abnormal  and
healthy  tissue.  In  photodynamic  diagnosis,  a  solution  of
aminolaevulinic  acid  (ALA)  is  topically  placed  on  lesion  sur-
face.  ALA  is  a  protoporphyrin  IX  (PpIX)  precursor  which  is
an  endogenous  photosensitizer  (PS)  that  naturally  occurs  in
the  cellular  heme  biosynthetic  pathway.  After  ALA  is  local-
ized  into  the  cell,  it  enters  in  the  heme  biosynthesis  and
stimulates  the  PpIX  production.  This  PS  has  ﬂuorescence
properties,  and  accumulates  preferentially  in  abnormal  tis-
sues,  allowing  its  use  as  a  complementary  diagnostic  tool
[14,15].  A  higher  ALA-PpIX  production  at  malignant  cells  has
been  observed  at  several  studies  [14,16,17],  supporting  ALA
use  as  a  potential  marker  for  photodynamic  diagnosis.
For  diagnostic  applications,  after  ALA  solution  is  admin-
istered  to  the  target  tissue,  a  time  interval  is  required  for
enough  PpIX  production  and  accumulation  allowing  its  ﬂuo-
rescence  visualization  at  the  interrogated  tissue.  Then,  skin
is  illuminated  using  light  at  the  UV-blue  spectral  range,  in
order  to  excite  the  PpIX  molecules  inside  the  tumor  cells  and
to  induce  their  ﬂuorescence  emission.  Under  this  excitation
range,  the  PpIX  shows  an  intense  orange-red  ﬂuorescence,
which  strongly  contrasts  with  the  green  autoﬂuorescence  of
the  biological  tissues.
In  this  clinical  study,  the  efﬁcacy  of  ALA  photodynamic
detection  (ALA-PDD)  of  malignant,  potentially  malignant
and  benign  skin  lesions  was  investigated.  To  the  best  of  our
knowledge,  there  is  no  analysis  evaluating  the  best  ALA  con-
centration  for  the  photodynamic  detection  of  skin  lesions.
The  aim  of  the  present  study  was  to  evaluate  the  efﬁcacy  of
a  clinical  protocol  for  the  ALA-PDD  for  the  detection  of  skin
lesions.
Material and methods
Patient  accrual
In  this  study,  43  patients  of  both  genders,  Caucasian,
between  45  and  91  years  old,  with  BCC,  AK,  and  SK  were
investigated  between  May  2010  and  June  2011.  A  total  of  71
lesions  were  imaged:  29  BCC,  31  AK,  and  11  SK.
All  lesions  were  clinically  diagnosed,  and  BCC  was  con-
ﬁrmed  by  histopathology.  All  patients  were  evaluated  at  the
Skin  Department  of  Amaral  Carvalho  Hospital,  and  all  under-
went  surgery  after  ﬂuorescence  evaluation.  This  research
was  approved  by  the  Review  Board  on  Ethics  in  Research
from  the  Amaral  Carvalho  Hospital  Foundation  (CEPFHAC
123/2010).  Patients  and  their  respective  caregivers  signed
an  informed  written  consent  for  participation  in  the  clinical
study.
Photosensitization
The  pro-drug  used  was  5-aminolevulinic  acid  (5-ALA  —
FSUESCC  ‘‘NIOPIIK’’  B  SADAVAYAd.  1k4,  Moscow,  Russia)
manipulated  at  concentrations  of  5%  and  10%  in  Milli-Q
water  solution  with  3%  of  dimethylsulfoxide  (DMSO)  and
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Figure  1  Skin  lesions  images  using  white  light  illumination  (left  column),  autoﬂuorescence  (central  column)  and  1  h  after  appli-
cation ALA  (right  column).  The  lines  show  typical  images  for:  BCC  (top),  AK  (center),  and  SK  (bottom).
1  mM  ethylenediaminetetraacetic  acid  (EDTA).  DMSO  is  an
enhancer  of  ALA  penetration  in  tissue,  and  EDTA  inhibits
the  enzyme  ferrochelatase,  resulting  in  a  higher  concentra-
tion  of  PpIX  in  cells.  The  PpIX  production  occurs  inside  the
mitochondria,  and  it  is  induced  by  the  ALA  present  in  the
biosynthetic  heme  pathway  [18—20].
Fluorescence  device
The  ﬂuorescence  evaluation  was  performed  using  a  home-
made  handheld  device  for  wideﬁeld  ﬂuorescence  imaging.
The  illumination  system  is  composed  of  a  set  of  LED  arrays
with  emission  between  380—420  nm,  with  peak  in  400  nm
and  irradiance  at  50  mW/cm2.  Three  optical  components
are  used:  a  ﬁlter  at  the  excitation  path  (band-pass  ﬁlter
between  390  nm  and  460  nm),  a  dichroic  mirror  (reﬂection
of  the  blue  spectrum  and  transmission  of  the  green—red
spectrum),  and  a  ﬁlter  at  the  collection  path  (long-pass  ﬁl-
ter,  over  475  nm).  This  optical  arrangement  was  designed
to  improve  the  contrast  visualization  (difference  between
colors  and  intensities)  of  light  in  green  and  red  regions  of
the  visible  spectrum,  main  ﬂuorescence  emissions  of  the
biological  tissue  and  PpIX,  respectively.  A  digital  color  cam-
era  (Sony  DSC-H50)  was  coupled  at  the  device  through  an
adapter  for  image  acquisition  [21].
Clinical  protocol
The  skin  lesions  were  initially  evaluated  under  conventional
white  light  and  dermatoscopy  by  a  certiﬁed  dermatolo-
gist  (AGS),  and  the  clinical  characteristics  described  at  the
patient  chart.
Solutions  of  ALA  5%  or  10%  were  prepared,  and  immersed
in  a  warm  bath  for  total  dissolution  of  ALA.  After  that,  the
solution  was  kept  at  room  temperature,  protected  from  light
until  the  moment  of  use.
Lesions  were  cleaned  with  chlorhexidine  soap,  and
cleansed  with  NaCl  0.9%  solution.  No  curettage  proce-
dure  was  performed  in  the  interrogated  lesions,  because
our  aim  was  to  analyze  the  efﬁcacy  of  the  photody-
namic  diagnostics  without  any  invasive  procedure,  so
variations  due  to  the  inherent  lesion  characteristics,
like  surface  keratin  and  dead  cell  layers,  could  not  be
avoided.
Five  percent  ALA  solution  was  applied  on  54  lesions  (21
BCCs,  22  AK,  and  11  SK).  In  order  to  determine  if  a  higher
pro-drug  concentration  could  improve  the  photodynamic
detection,  10%  ALA  solution  was  applied  on  17  lesions  (8
BCCs  and  9  AK),  and  the  same  analysis  parameters  were
performed.
The  ALA  solution  was  applied  over  the  lesion  surface,
covering  all  clinical  margins.  After  the  pro-drug  applica-
tion,  the  lesions  were  protected  from  light  exposure  using
an  occlusive  curative  with  PVC  plastic  ﬁlm,  aluminum  foil
and  bandage.  Images  were  collected  at  regular  time  inter-
vals  (15,  30,  45  and  60  min)  in  a  dark  room.  At  each  time
interval,  the  curative  was  removed  for  image  collection,  and
replaced  just  after  imaging.
The  images  were  processed  using  an  algorithm  writ-
ten  in  Matlab® 7.5  (MathWorks,  USA)  for  evaluation  of
PpIX  ﬂuorescence  emission.  This  algorithm  determines  the
number  of  pixels  for  the  component  R  (‘‘red’’)  in  the
RGB  matrix  for  each  image,  attributing  them  to  red  light
intensity,  which  was  associated  to  the  photosensitizer  ﬂuo-
rescence.
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Statistics
Data  are  expressed  as  average  values  and  standard  devi-
ations.  The  Shapiro—Wilk  test  was  used  to  determine  the
normality  of  the  data.  To  compare  differences  between
lesions  and  normal  tissue,  before  and  after  ALA  applica-
tion  paired  Student’s  t-test  was  used,  and  for  discrimination
between  lesion  and  normal  tissue,  unpaired  Student’s  t-test
was  applied.
The  software  Statistica  for  Windows,  release  7  (Statsoft,
Tulsa,  OK)  was  used  for  the  statistical  analysis  and  the  sig-
niﬁcance  level  was  set  at  5%  (p  <  0.05).
Results
ALA  5%
The  image  sequence  in  Fig.  1  shows  the  PpIX  production  over
time  in  a  BCC  at  right  temporal  (Fig.  1a—c),  an  AK  at  the
right  forearm  (Fig.  1d—f)  and  a  SK  at  the  chest  (Fig.  1g—i).
The  left  column  shows  the  image  of  skin  lesions  under  white
light  illumination  (Fig.  1a,  d,  g);  the  central  column  their
autoﬂuorescence  (Fig.  1b,  e,  i);  and  the  right  column,  typ-
ical  lesion  photodynamic  ﬂuorescence,  one  hour  after  ALA
application.
Healthy  tissue  shows  ﬂuorescence  at  the  green  region  of
the  spectrum,  and  abnormal  tissues,  as  BCC,  AK,  and  SK,
show  loss  of  ﬂuorescence  emission  (LOF),  visualized  as  a
darker  region.  The  red  ﬂuorescence  at  Fig.  1c,  is  observed  at
the  same  regions  previously  associated  with  LOF.  The  visu-
alized  bright  spots  correspond  to  areas  of  high  ﬂuorescence
emission  (Fig.  1e  and  f)  from  hyper-keratinized  areas  of  the
lesion  surface.  It  can  be  noted  that  SK  does  not  ﬂuoresce
(Fig.  1h),  visualized  as  a  dark  region  with  several  ﬂuores-
cent  points.  This  autoﬂuorescence  pattern  is  related  to  a
high  melanin  content  that  extensively  absorbs  both  excita-
tion  and  ﬂuorescence  lights,  and  to  the  corneal  structures
inside  the  lesion,  resulting  in  LOF  and  highly  ﬂuorescent
spots,  respectively  [9,22].  No  qualitative  visualization  of  the
PpIX  production  could  be  observed  at  the  AK  and  SK.
To  quantify  the  PpIX  showed  in  the  images,  regions  at
both  normal  and  lesion  tissue  were  selected,  and  the  inten-
sity  of  red  ﬂuorescence  was  calculated  for  each  image.
Then,  intensity  was  normalized  by  its  background  red  inten-
sity  (the  red  emission  present  at  tissue  autoﬂuorescence),
to  obtain  only  the  contribution  of  the  PpIX  emission  in  the
tissue  ﬂuorescence  after  the  ALA  treatment.  Fig.  2  shows
graphs  of  PpIX  intensity  emission  as  a  function  of  time  of
the  three  lesions  shown  in  Fig.  1.  It  is  possible  to  observe
that  the  PpIX  ﬂuorescence  intensity  increases  with  time  for
BCC,  while  remains  almost  constant  for  the  other  lesions,
enhancing  the  qualitative  analysis.
Statistical  tests  were  performed  to  determine  whether
there  was  signiﬁcant  difference  between  the  ﬂuorescence
of  the  lesion  and  normal  tissue  (before  and  after  ALA  appli-
cation)  and  between  these  lesions  before  and  after  ALA
application.  In  order  to  show  that  the  PpIX  production
occurs  preferentially  in  abnormal  cells,  tests  were  also  per-
formed  by  evaluating  normal  tissue  before  and  after  ALA
application.
Figure  2  Graphics  of  red  ﬂuorescence  intensity  versus  appli-
cation  time  of  ALA  for  lesions  shown  in  Fig.  1.  BCC,  AK  and
SK, respectively.  The  line  corresponds  to  the  red  ﬂuorescence
present in  ﬂuorescence  from  the  healthy  skin.
In  the  comparison  between  lesion  and  normal  tissue  prior
to  ALA  application  (autoﬂuorescence),  there  was  signiﬁcant
difference  in  all  cases  (p  <  0.01).  The  same  was  true  when
comparing  the  lesion  and  normal  tissue  60  min  after  ALA
application  (p  <  0.01).
When  the  lesion  autoﬂuorescence  was  compared  with
the  values  of  ﬂuorescence  60  min  after  ALA  application,
there  was  signiﬁcant  difference  (p  <  0.01)  only  for  the  BCC.
Comparison  between  normal  tissue  before  and  60  min  after
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Figure  3  Skin  lesions  images  using  white  light  illumination  (left  column),  autoﬂuorescence  (central  column)  and  1  hour  after
application ALA  (right  column).  The  lines  show  typical  images  for:  BCC  (top)  and  AK  (bottom).
ALA  application  showed  no  statistical  signiﬁcance  for  any
group.
ALA  10%
The  images  in  Fig.  3  show  PpIX  ﬂuorescence  emission  over
time  in  a  BCC  lesion  (Fig.  1a—c)  and  an  AK  lesion  (Fig.  1d—f).
The  left  column  shows  the  skin  lesions  under  white  light
illumination  (Fig.  1a  and  d);  the  central  column,  their  auto-
ﬂuorescence  (Fig.  1b  and  e);  and  the  right  column,  lesion
ﬂuorescence  one  hour  after  ALA  application.
For  AK  lesion,  the  result  was  similar  to  5%  ALA.  For  BCC
lesion,  however,  a  reduced  production  of  PpIX  was  observed,
although  the  quantitative  analysis  showed  an  increase  in
PpIX  ﬂuorescence  intensity  (Fig.  4),  it  was  preferentially
located  at  the  lesion  borders  as  showed  in  Fig.  3c.  Here  it
is  important  to  point  out  that  this  BCC  lesion,  in  compari-
son  to  the  one  in  Fig.  1a,  showed  a  higher  necrotic  tissue
at  lesion  surface,  preventing  an  efﬁcient  penetration  of  the
ALA  solution,  due  to  a  non-curettage  of  these  lesions,  the
PpIX  emission  was  observed  at  the  lesion  regions  of  less
keratinized  surface.
The  statistical  tests  for  comparison  between  lesion  and
normal  tissue,  both  prior  to  ALA  application  (autoﬂuores-
cence)  and  60  min  after,  showed  signiﬁcant  differences  in
all  cases  (p  <  0.01).  When  lesion  and  normal  tissues’  auto-
ﬂuorescence  was  compared  to  ﬂuorescence  intensity  values
60  min  after  ALA  application,  no  signiﬁcant  difference  was
observed.
Discussion
The  observed  LOF  from  the  abnormal  skin  has  been  also
described  in  other  studies  [12,23,24],  and  this  is  mainly
justiﬁed  by  the  decrease  in  collagen  ﬂuorescence  caused
by  ﬁber  linkage  breakdown  [25].  Others  skin  components
such  as  ﬂavins  do  not  have  a  great  contribution  due  to  the
excitation  wavelength,  which  is  not  within  the  absorption
wavelengths  of  these  components  [26].
Fluorescence  images  after  the  ALA  application  show  pref-
erential  accumulation  of  PpIX  in  skin  areas  associated  or
within  the  BCC  lesions,  representing  a potential  aid  to  the
cancer  diagnosis,  since  it  increases  the  visualization  contrast
between  normal  and  abnormal  tissue.  With  this  increase  in
contrast,  an  improved  discrimination  of  the  lesion  superﬁ-
cial  margins  is  provided,  information  highly  important  for
the  treatment  planning  and  execution.
The  difference  between  the  autoﬂuorescence  from
normal  and  abnormal  tissue  is  noticeable.  This  obser-
vation  is  in  agreement  with  other  studies  in  liter-
ature  which  demonstrate  a reduction  of  the  green
ﬂuorescence  at  skin,  and  an  increase  in  the  red  ﬂu-
orescence  for  lesions  [16,17,27]. After  application  of
the  ALA  solution,  the  difference  between  tissues  is
more  evident  with  time,  when  considering  the  red
ﬂuorescence  emission.  The  use  of  the  photodynamic
diagnosis  only  showed  a  response  for  BCC  lesion,  but  there
was  no  improvement  at  the  visual  discrimination  to  the  auto-
ﬂuorescence  detection.
A  possible  reason  for  the  lesions  in  which  there  was  no
increase  in  the  red  ﬂuorescence  emission  is  the  ineffec-
tive  penetration  of  ALA  solution;  mainly  caused  by  areas  of
hyper-keratinization  and  necrotic  tissue.
Several  lesions  of  BCC  and  AK  present  extensive  kera-
tinization  on  the  surface,  which  behaves  as  physical  barrier
to  the  penetration  of  ALA  solution  [28]. The  result  is  a  large
number  of  lesions  which  showed  no  increase  in  PpIX  ﬂuo-
rescence  even  60  min  after  ALA  application.  However,  this
keratin  layer  can  be  removed  by  curettage,  which  is  a  sim-
ple  medical  procedure.  Indeed,  the  curettage  is  performed
in  ALA-photodynamic  therapy  (PDT)  for  the  removal  of  the
keratin  and  dead  cells  layers  to  improve  the  pro-drug  pene-
tration  [29,30]. In  the  investigated  protocol,  the  curettage
was  not  performed,  since  the  aim  was  to  verify  the  efﬁcacy
of  the  photodynamic  detection  using  a  procedure  with  the
least  possible  number  of  steps.  Based  on  the  present  results,
an  improved  performance  and  diagnostic  resolution  may  be
achieved,  if  the  curettage  is  performed  previously  to  ALA
solution  placement.
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Figure  4  Graphics  of  red  ﬂuorescence  intensity  versus  application  time  of  ALA  for  BCC  and  AK  lesions  showed  in  Fig.  3.  The  line
corresponds  to  the  red  ﬂuorescence  in  ﬂuorescence  from  the  healthy  skin.
For  SK,  the  high  light  absorption  by  melanin  hinders
ﬂuorescence  visualization,  in  both  autoﬂuorescence  and
photodynamic  detection.
However,  for  SK  and  AK  lesions,  the  autoﬂuorescence
detection  presents  already  an  improved  visualization  of  the
lesion.  The  photodynamic  detection  did  not  show  a signiﬁ-
cantly  increase  in  the  red  ﬂuorescence  intensity.  Therefore,
sensitization  has  shown  to  be  important  only  for  BCC  lesions.
The  autoﬂuorescence  for  SK  lesions  may  help  on  the
differential  diagnostics  to  melanoma.  The  corneum  pseu-
docysts,  a  tissue  structure  that  differentiates  the  SK  from
melanoma,  become  evident  in  autoﬂuorescence  images
[22,31].  In  melanoma  lesions,  the  autoﬂuorescence  pattern
is  an  evident  LOF,  visualized  as  a  dark  area  without  any
ﬂuorescent  spots.
The  anatomical  site  also  plays  an  important  role  on  the
penetration  of  the  ALA  solution.  Lesions  that  are  located  in
the  arm  and  forearm  usually  present  a  thicker  layer  of  ker-
atin  than  those  located  in  the  head  and  neck,  reducing  the
pro-drug  penetration.  In  arm/forearm  cases,  the  PpIX  ﬂuo-
rescence  emission  was  less  intense  in  the  lesions  borders,
as  well  as  less  intense  when  compared  to  cases  in  head  and
neck.
Even  when  the  ALA  concentration  is  increased  from  5%  to
10%,  most  of  the  lesions  did  not  show  enough  accumulation
of  PpIX,  reinforcing  the  hypothesis  of  the  physical  barrier
impairing  an  efﬁcient  tissue  photosensitization  [15,32,33].
Although  curettage  has  been  already  used  for  other  pro-
tocols  as  a  safe  and  effective  practice  [29,30],  this  study
aimed  to  verify  how  feasible  this  technique  could  be  with
no  application  of  any  invasive  procedure.
Conclusion
Fluorescence  investigation  of  BCC  lesions,  using  both
autoﬂuorescence  and  photodynamic  detection  techniques,
showed  ability  to  signiﬁcantly  differentiate  normal  from
tumor  tissue.  PpIX  accumulation  in  skin  lesions  increases
visual  contrast  between  healthy  and  abnormal  tissues.  This
contrast  allows  for  improved  identiﬁcation  of  lesion  margins.
For  detection  of  non-malignant  skin  lesions,  AK  and
SK,  the  use  of  autoﬂuorescence  images  only  proved  to  be
sufﬁcient;  no  additional  information  was  provided  by  using
photodynamic  diagnosis.  In  the  case  of  AK,  due  to  excessive
keratin  at  lesion  surface,  ALA  solution  did  not  adequately
penetrate  into  the  tissue  to  induce  PpIX  production.  For
SK  lesions,  with  higher  melanin  content,  autoﬂuorescence
images  result  in  tissue  LOF,  with  highly  ﬂuorescent  spots
inside  the  lesion.  These  spots  are  corneum  pseudocysts,
which  are  characteristic  structures  at  those  lesions.  There-
fore,  observing  them  contributes  to  diagnosis,  especially  to
differentiate  them  from  melanoma.
Increasing  concentration  of  ALA  form  5%  to  ALA  10%  for
BCC  and  AK  showed  that  the  low  PpIX  production  was  not  due
to  low  concentration,  but  to  the  limited  penetration  of  the
pro-drug  solution,  which  might  be  managed  by  performing
curettage  on  lesions  prior  to  ALA  administration.
Wideﬁeld  ﬂuorescence  imaging  is,  therefore,  a  poten-
tial  auxiliary  tool  for  skin  diagnosis,  helping  to  deﬁne  the
lesions  margins;  and  ALA-mediated  photodynamic  detec-
tion  showed  to  be  able  to  increase  visual  contrast  of  BCC
lesions.
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